PRESTIGE CONSUMER HEALTHCARE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.97 USD | +0.22% |
|
-1.05% | +4.49% |
| May. 15 | Sector Update: Health Care Stocks Rise Pre-Bell Wednesday | MT |
| May. 15 | Transcript : Prestige Consumer Healthcare Inc., Q4 2024 Earnings Call, May 15, 2024 |
Chart calendar Prestige Consumer Healthcare Inc.
5b96020a38cf27923.0OGDExf64zhhLM2YnT-6hSUMdQqko_9mY5pOq0Z_DkA.sqLQRyCDkmcFfPj1-wj-s0J1WE3rzJ4gKfUpxgwaeQOIma5ML5aEVwIbog~47f2e0116d655996a29e916de2e24d8d
Upcoming events on Prestige Consumer Healthcare Inc.
Past events on Prestige Consumer Healthcare Inc.
| 2024-05-15 08:30 am | Q4 2024 Earnings Call |
| 2024-05-14 05:00 pm | Q4 2024 Earnings Release |
| 2024-02-08 08:30 am | Q3 2024 Earnings Call |
| 2024-02-08 06:00 am | Q3 2024 Earnings Release |
| 2023-11-02 08:30 am | Q2 2024 Earnings Call |
| 2023-11-02 06:00 am | Q2 2024 Earnings Release |
| 2023-09-20 01:45 pm | Sidoti Small Cap Conference |
| 2023-09-07 03:00 pm | Barclays Global Consumer Staples Conference |
| 2023-08-08 02:00 pm | Canaccord Genuity Growth Conference |
| 2023-08-03 08:30 am | Q1 2024 Earnings Call |
| 2023-08-03 06:00 am | Q1 2024 Earnings Release |
| 2023-08-01 10:00 am | Annual General Meeting |
| 2023-06-12 09:45 am | Oppenheimer Consumer Growth and E-Commerce Conference |
| 2023-06-06 01:00 pm | William Blair Growth Stock Conference |
| 2023-05-04 08:30 am | Q4 2023 Earnings Call |
| 2023-05-04 06:00 am | Q4 2023 Earnings Release |
| 2023-02-02 08:30 am | Q3 2023 Earnings Call |
| 2023-02-02 06:00 am | Q3 2023 Earnings Release |
| 2023-01-10 02:30 pm | ICR Conference |
| 2022-11-03 08:30 am | Interim 2023 Earnings Call |
Annual results
| Fiscal Period | March | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 963 951 1.22% | 943 936 0.76% | 1 087 1 078 0.81% | 1 128 1 121 0.62% | 1 125 1 136 -0.91% | 1 129 |
|
EBITDA Million USD | Released Forecast Spread | 328 326 0.76% | 329 329 -0.04% | 368 367 0.12% | 378 382 -1.04% | 374 383 -2.44% | 376 |
|
EBIT Million USD | Released Forecast Spread | 299 295 1.49% | 299 298 0.37% | 327 333 -1.84% | 348 346 0.52% | 342 351 -2.43% | 342 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 191 192 -0.34% | 204 217 -5.81% | 262 266 -1.42% | -93,9 274 -134.24% | 276 283 -2.62% | 289 |
|
Net income Million USD | Released Forecast Spread | 142 145 -1.69% | 165 169 -2.56% | 205 202 1.88% | -82,3 210 -139.12% | 209 217 -3.42% | 220 |
|
EPS USD | Released Forecast Spread | 2,78 2,83 -1.77% | 3,25 3,30 -1.4% | 4,04 3,97 1.7% | -1,65 4,18 -139.44% | 4,17 4,33 -3.73% | 4,40 |
| Announcement Date | 07/05/20 | 06/05/21 | 05/05/22 | 04/05/23 | 14/05/24 | - |
Quarterly results
| Fiscal Period | Maart | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 267 258 3.36% | 277 269 3.02% | 289 283 2.13% | 276 274 0.61% | 286 281 1.88% | 279 278 0.34% | 286 285 0.39% | 283 280 0.85% | 277 287 -3.61% | 261 | 282 | 293 | 293 | 275 |
|
EBITDA Million USD | Released Forecast Spread | 85,4 83,5 2.25% | 94,6 94,2 0.43% | 91,8 92,5 -0.78% | 94,2 93,4 0.83% | 97,5 96,1 1.5% | 94,0 93,7 0.31% | 95,7 96,4 -0.8% | 93,8 93,4 0.44% | 90,4 98,5 -8.24% | 79,8 | 95,0 | 100 | 101 | 94,4 |
|
EBIT Million USD | Released Forecast Spread | 76,9 75,1 2.51% | 86,2 85,7 0.62% | 83,6 83,5 0.11% | 86,0 84,7 1.55% | 89,2 87,5 1.99% | 85,2 84,6 0.72% | 88,3 88,1 0.15% | 86,8 85,4 1.7% | 82,2 90,7 -9.41% | 71,5 | 86,3 | 91,9 | 92,7 | 82,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 61,0 59,3 2.78% | 70,9 70,1 1.14% | 66,6 67,4 -1.15% | 68,1 67,3 1.28% | -300 68,7 -536.13% | 68,7 66,1 3.95% | 70,4 70,4 0.06% | 69,6 68,6 1.42% | 67,3 74,8 -9.94% | 56,8 | 72,1 | 79,1 | 81,3 | 71,1 |
|
Net income Million USD | Released Forecast Spread | 52,1 44,9 15.9% | 55,3 53,3 3.73% | 51,0 50,8 0.36% | 52,0 51,1 1.69% | -241 52,2 -560.76% | 53,3 50,2 6.06% | 53,6 53,5 0.13% | 53,0 52,1 1.75% | 49,5 56,9 -13.03% | 43,3 | 54,9 | 60,3 | 61,9 | 54,2 |
|
EPS USD | Released Forecast Spread | 1,02 0,89 15.25% | 1,09 1,05 4.31% | 1,02 1,00 1.59% | 1,04 1,01 2.77% | -4,83 1,04 -564.42% | 1,06 1,01 5.47% | 1,07 1,07 0.31% | 1,06 1,04 1.76% | 0,98 1,14 -14.04% | 0,86 | 1,09 | 1,20 | 1,24 | 1,09 |
| Announcement Date | 05/05/22 | 04/08/22 | 03/11/22 | 02/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 08/02/24 | 14/05/24 | - | - | - | - | - |
More events
Past sector events for Prestige Consumer Healthcare Inc.
| 2024-05-24 | BLUE JET HEALTHCARE LIMITED: Q4 2024 Earnings Release |
| 2024-05-24 | AUROBINDO PHARMA: Q4 2024 Earnings Release |
| 2024-05-24 | DIVI'S LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-24 08:18 am | TORRENT PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-24 10:56 am | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED: Q4 2024 Earnings Release |
| 2024-05-23 10:47 am | ORCHID PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-23 06:45 am | SHILPA MEDICARE LIMITED: Q4 2024 Earnings Release |
| 2024-05-22 08:06 am | GLAND PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-21 06:57 am | ERIS LIFESCIENCES LIMITED: Q4 2024 Earnings Release |
| 2024-05-20 05:00 pm | TARO PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PBH Stock
- Calendar Prestige Consumer Healthcare Inc.
